ArticleBioengineered2019

Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.

Tingting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.